Background and aims: Refractory hydrothorax (RH) significantly impairs quality of life and clinical outcomes in patients with cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) has been suggested as a potential treatment, but evidence is limited. We assessed TIPS effectiveness and impact on survival in patients with RH. Methods: Consecutive patients with cirrhosis undergoing TIPS for RH over a 16-year period across 18 European centers were included. Clinical response was assessed up to 12 months after TIPS and was classified as complete (CR: disappearance of symptoms and no further thoracenteses), partial (PR: decrease of symptoms and ≥50% reduction of thoracenteses) or no response (NR: minor or no relief in symptoms and <50% reduction or same/increased number of thoracenteses). Results: Overall, 147 patients were included. TIPS achieved CR in 88 patients (60%). Mortality rates were 1.54, 5.34, and 11.4 deaths per 100 patient-months in patients with CR, PR, and NR, respectively. Time-dependent cause-specific Cox models showed a significant lower risk of death in CR patients compared with both those with PR (HR = 0.33, 95% CI 0.15-0.73; p = 0.006) and NR (HR = 0.15, 95% CI 0.06-0.37; p < 0.001). At multivariable analysis, CR remained independently associated with improved survival (HR = 0.30, 95% CI 0.14-0.64; p = 0.002). Conclusion: Among patients with cirrhosis and RH selected to undergo TIPS, clinical CR was achieved in a substantial proportion and was independently associated with improved survival.

TIPS for refractory hepatic hydrothorax in patients with cirrhosis: impact of clinical response on survival / Tizzani, M., Caviglia, G.P., Téllez, L., Geisselbrecht, S., Vizzutti, F., Reincke, M., Becchetti, C., Maruzzelli, L., Saltini, D., Rudler, M., Ferdinande, K., Pompili, E., Larrue, H., Tosetti, G., Nardelli, S., Campion, D., Donate, J., Tiede, A., Aspite, S., Schultheiss, M., et al.. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - ELETTRONICO. - (2026), pp. 0-0. [10.1016/j.cgh.2026.10.034]

TIPS for refractory hepatic hydrothorax in patients with cirrhosis: impact of clinical response on survival

Vizzutti, Francesco;Aspite, Silvia;Marra, Fabio;Ragozzino, Lucia;Falcini, Margherita;
2026

Abstract

Background and aims: Refractory hydrothorax (RH) significantly impairs quality of life and clinical outcomes in patients with cirrhosis. Transjugular intrahepatic portosystemic shunt (TIPS) has been suggested as a potential treatment, but evidence is limited. We assessed TIPS effectiveness and impact on survival in patients with RH. Methods: Consecutive patients with cirrhosis undergoing TIPS for RH over a 16-year period across 18 European centers were included. Clinical response was assessed up to 12 months after TIPS and was classified as complete (CR: disappearance of symptoms and no further thoracenteses), partial (PR: decrease of symptoms and ≥50% reduction of thoracenteses) or no response (NR: minor or no relief in symptoms and <50% reduction or same/increased number of thoracenteses). Results: Overall, 147 patients were included. TIPS achieved CR in 88 patients (60%). Mortality rates were 1.54, 5.34, and 11.4 deaths per 100 patient-months in patients with CR, PR, and NR, respectively. Time-dependent cause-specific Cox models showed a significant lower risk of death in CR patients compared with both those with PR (HR = 0.33, 95% CI 0.15-0.73; p = 0.006) and NR (HR = 0.15, 95% CI 0.06-0.37; p < 0.001). At multivariable analysis, CR remained independently associated with improved survival (HR = 0.30, 95% CI 0.14-0.64; p = 0.002). Conclusion: Among patients with cirrhosis and RH selected to undergo TIPS, clinical CR was achieved in a substantial proportion and was independently associated with improved survival.
2026
0
0
Tizzani, Marco; Caviglia, Gian Paolo; Téllez, Luis; Geisselbrecht, Sophia; Vizzutti, Francesco; Reincke, Marlene; Becchetti, Chiara; Maruzzelli, Luigi...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1501232
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact